Systemic Inflammatory Indices as a Non-invasive Grading Modality for Endometriosis
NCT ID: NCT06298617
Last Updated: 2024-03-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
88 participants
OBSERVATIONAL
2023-01-01
2023-12-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improvement in Quality of Life and Pain Scores After Laparoscopic Management of Deep Infiltrating Endometriosis
NCT04062916
Endometriosis and Complement System
NCT06495151
Superficial and Deep Endometriosis: Role of Systemic Inflammation as a Marker of Clinical, Surgical, and Reproductive Outcomes
NCT06470594
Evaluation of the Ovarian Reserve in Infertile Patients With Endometriosis
NCT01941017
Pelvic Neuro-Angiogenesis in Deep Endometriosis
NCT06286371
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
Diagnostic laparoscopy
All women will undergo exploratory laparoscopy under general anesthesia
Full Blood Count (FBC)
Blood samples withdrawn from patients on EDITA tubes and gone through full blood count and differential leucocytic count
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diagnostic laparoscopy
All women will undergo exploratory laparoscopy under general anesthesia
Full Blood Count (FBC)
Blood samples withdrawn from patients on EDITA tubes and gone through full blood count and differential leucocytic count
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women who was professionally diagnosed;
* Women who was diagnosed by radiologic workup;
Exclusion Criteria
* Patients had autoimmune diseases, maintained on immunosuppressive therapy for any indication;
* Women with cancer elsewhere in the body or receiving adjuvant therapies for cancer;
* Patients receiving therapies for viral disorders especially COVID;
* Patients refusing to undergo the exploratory laparoscopy.
25 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Benha University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Sabra
Lecturer of Obstetrics & Gynecology Department, Faculty of Medicine.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Benha University
Banhā, Al Qalyobia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC 27.1.2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.